MedTrace Logo

CT-FFR-guided Strategy for In-stent Restenosis

NCT05611190 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2022-11-09

No results posted yet for this study

Summary

This study will be a prospective, randomized clinical trial to compare standard practice guided by usual care testing to CT-FFR-guided management in patients with in-stent restenosis.

Conditions

Interventions

DIAGNOSTIC_TEST

CT-FFR

CT-FFR is a type of non-invasive procedure to provide a 3D model of coronary arteries as a way to evaluate the hemodynamic significance of coronary artery lesions. CT-FFR calculates FFR from subject-specific CCTA data using computational fluid dynamics technology. CT-FFR value ≤0.80 is considered hemodynamically significant.

DIAGNOSTIC_TEST

Usual Care

Participants randomized to usual care will be evaluated according to institutional standard practice.

Sponsors & Collaborators

  • Yan'an Affiliated Hospital of Kunming Medical University

    lead OTHER

Principal Investigators

  • Qiang Xue · Yan'an Affiliated Hospital of Kunming Medical University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-12
Primary Completion
2024-12-11
Completion
2025-12-11

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611190 on ClinicalTrials.gov